Science
Artificial endometrial chip developed to mimic hormonal responses Real-time observation from embryo attachment through cellular rearrangement

The “black box” of human embryo implantation has finally been opened. The entire process of embryo implantation has been captured for the first time worldwide on an artificial endometrial chip.
According to BioOn, a Chinese biology news outlet, on the 3rd local time, the latest findings from a study modeling the attachment process of human embryos were published in the international journal Science Advances. The research team developed a 2-channel microfluidic chip, named “ADOC,” by separating epithelial cells and stromal cells from patients’ endometrial tissue.
The researchers treated the chip with the female hormones estrogen and progesterone, successfully mimicking the “receptive state” in which the uterus has completed preparations to receive an embryo. After hormone treatment, the stromal cells expressed genes associated with decidualization, and their overall transcriptomic characteristics closely matched those of the secretory-phase endometrium in the human body.
When human embryos were placed on the validated chip and observed, the embryos’ “polar trophectoderm,” a specific region, was seen attaching first to the endometrial epithelial cells. Subsequently, dynamic changes were observed inside the embryos, including the radial rearrangement of the epiblast layer and the migration of primitive endoderm cells toward the attachment surface.
In particular, the trophectoderm cells of embryos that successfully attached began secreting human chorionic gonadotropin (hCG), a marker used for pregnancy diagnosis, and hormone levels in the culture medium also increased. This indicates that the chip reproduced not only physical attachment but also biological function.
By contrast, embryos in the control groups that did not receive hormone treatment or were administered the progesterone antagonist mifepristone failed to attach stably. This clearly demonstrates that a specific hormone-induced period, known as the “implantation window,” is an essential condition for implantation.
The study is being viewed as having brought the early stages of embryo implantation, which had remained largely in the realm of speculation, into the domain of science, where they can be observed, measured and manipulated. The ADOC chip used in the study is expected to contribute to identifying the causes of recurrent implantation failure, assessing endometrial receptivity, and developing new assisted reproductive technologies and nonhormonal contraceptives.

BIOBOOK TEAM
biobookmedia@biobook.co.kr
“Reaching the brain with a subcutaneous injection” … Arrowhead cuts Alzheimer’s tau protein by 73%

Verastem Sets a “New Standard” for KRAS-Targeted Drug, With 80% Survival Rate in Pancreatic Cancer

Celltrion Wins South Korean Approval for Phase 3 Trial of Zymfentra in Rheumatoid Arthritis

AptaBio Reports Safety in Phase 2 Trial of Contrast-Induced Kidney Injury Treatment

Oral GLP-1 diabetes drug improves blood sugar and weight in Chinese phase 3 trial

Google Deploys ‘Gemini 4 Argon’ in Drug Development, Boosting Molecular Computation Speed by 2.3-Fold